Physician profile
Rachael E Mccabe
NPI 1366852683
$6,535.77
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,162 · 2020: $3,000 · 2021: $14.80 · 2022: $350 · 2023: $985 · 2024: $23.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $790 · Food and Beverage: $194 · Education: $23.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $790.36 |
| Food and Beverage | $194.33 |
| Education | $23.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,800.04 | 2019-2024 | Da Vinci Surgical System |
| Gynesonics, INC. | $371.02 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Conmed Corporation | $119.81 | 2022 | |
| Merck Sharp & Dohme LLC | $51.96 | 2019 | |
| Abbvie INC. | $46.39 | 2019 | |
| Ethicon US, LLC | $32.90 | 2019 | |
| Roche Diagnostics Corporation | $31.67 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.57 | 2019 | |
| Daiichi Sankyo INC. | $22.22 | 2019 | |
| Hologic Sales and Service, LLC | $14.80 | 2021 | |
| Pfizer INC. | $13.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachael Mccabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.